121 related articles for article (PubMed ID: 2207304)
1. Pharmacokinetics and safety of single oral doses of lomefloxacin.
Morse IS
Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of lomefloxacin following multiple doses.
Hunt TL; Adams MA
Diagn Microbiol Infect Dis; 1989; 12(2):181-7. PubMed ID: 2752716
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of lomefloxacin in renally compromised patients.
Blum RA; Schultz RW; Schentag JJ
Antimicrob Agents Chemother; 1990 Dec; 34(12):2364-8. PubMed ID: 2088191
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of lomefloxacin: rationale for once-a-day dosing.
Mant TG
Am J Med; 1992 Apr; 92(4A):26S-32S. PubMed ID: 1316066
[TBL] [Abstract][Full Text] [Related]
7. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
Kavi J; Stone J; Andrews JM; Ashby JP; Wise R
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):168-70. PubMed ID: 2498102
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days.
Gros I; Carbon C
Antimicrob Agents Chemother; 1990 Jan; 34(1):150-2. PubMed ID: 2327750
[TBL] [Abstract][Full Text] [Related]
9. Lack of interaction between lomefloxacin and caffeine in normal volunteers.
Healy DP; Schoenle JR; Stotka J; Polk RE
Antimicrob Agents Chemother; 1991 Apr; 35(4):660-4. PubMed ID: 2069371
[TBL] [Abstract][Full Text] [Related]
10. Lomefloxacin pharmacokinetics in subjects with normal and impaired renal function.
Leroy A; Fillastre JP; Humbert G
Antimicrob Agents Chemother; 1990 Jan; 34(1):17-20. PubMed ID: 2327756
[TBL] [Abstract][Full Text] [Related]
11. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
Wijnands GJ; Cornel JH; Martea M; Vree TB
Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Lebrec D; Gaudin C; Benhamou JP
Am J Med; 1992 Apr; 92(4A):41S-44S. PubMed ID: 1316069
[TBL] [Abstract][Full Text] [Related]
13. Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.
Stuht H; Lode H; Koeppe P; Rost KL; Schaberg T
Antimicrob Agents Chemother; 1995 May; 39(5):1045-9. PubMed ID: 7625786
[TBL] [Abstract][Full Text] [Related]
14. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
16. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H
Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768
[TBL] [Abstract][Full Text] [Related]
18. Renal clearance of lomefloxacin is decreased by furosemide.
Sudoh T; Fujimura A; Shiga T; Sasaki M; Harada K; Tateishi T; Ohashi K; Ebihara A
Eur J Clin Pharmacol; 1994; 46(3):267-9. PubMed ID: 8070509
[TBL] [Abstract][Full Text] [Related]
19. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
[TBL] [Abstract][Full Text] [Related]
20. Influence of lomefloxacin on the pharmacokinetics of theophylline.
LeBel M; Vallée F; St-Laurent M
Antimicrob Agents Chemother; 1990 Jun; 34(6):1254-6. PubMed ID: 2393286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
